Favorable prognosis was observed in patients presenting high expression of “luminal like” genes (AR, GATA3) and decreased survival was observed in patients expressing cancer stem cell-like (WNT11) or EMT-associated genes (MMP28) [87]. This evidence concerns the gene MMP28 and cancer.